Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Clopiwel AT
Clopiwel AT is an effective cardiovascular therapy combining Atorvastatin (a statin) and Clopidogrel (an antiplatelet drug). This combination is widely prescribed for reducing cholesterol levels, preventing blood clot formation, and lowering the risk of heart disease and stroke. Clopiwel AT provides comprehensive vascular protection for individuals at high cardiovascular risk.
Uses of Clopiwel AT
Clopiwel AT is indicated for:
Prevention of heart attacks (myocardial infarction) and strokes
Management of dyslipidemia (high cholesterol levels)
Atherosclerosis prevention and treatment
Peripheral artery disease (PAD) and coronary artery disease (CAD)
Post-stent placement therapy to prevent clot formation
Benefits of Clopiwel AT
Dual Cardiovascular Protection: Lowers cholesterol and prevents clot formation
Reduces Risk of Stroke & Heart Attack: Ideal for high-risk cardiac patients
Prevents Atherosclerosis Progression: Slows plaque buildup in arteries
Enhances Blood Circulation: Improves vascular health and oxygen delivery
Clinically Proven Combination Therapy: Trusted for long-term cardiovascular management
Mechanism of Action of Clopiwel AT
Atorvastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis and lowering LDL (bad cholesterol) and triglycerides while increasing HDL (good cholesterol).
Clopidogrel is a P2Y12 inhibitor that prevents platelet aggregation, reducing the risk of blood clots and preventing cardiovascular events.